What is the role of T cells in COVID-19 infection? Why immunity is about more than antibodies - The Centre for Evidence-Based Medicine
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells: Molecular Therapy - Methods & Clinical Development
Imaging of Activated T Cells | Journal of Nuclear Medicine
More on T Cells, Antibody Levels, and Our Ignorance | Science | AAAS
Frontiers | γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
Antibodies | Free Full-Text | Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
T Cell Immunity? | BioBus
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm | Journal of Nuclear Medicine
IJMS | Free Full-Text | Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy
An Introduction to Antibodies: Antigens, Epitopes and Antibodies
Decrease in Antibodies Against SARS-CoV-2 Over Time and Current Role of Serological Testing - Ontario COVID-19 Science Advisory Table
Overcoming the challenges associated with CD3+ T-cell redirection in cancer | British Journal of Cancer
Pharmaceuticals | Free Full-Text | T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
JCI - Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals
Antibodies + CAR-T Cells - Gene Center Munich - LMU Munich
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation: Molecular Therapy
T-cell Bispecific Antibodies | Genentech Oncology
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers | ACS Synthetic Biology
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV: Molecular Therapy - Methods & Clinical Development
Frontiers | Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies
The Search for Immune Responses that Stop COVID-19 | The Scientist Magazine®
Ovalbumin antigen-specific activation of T cell receptor closely resembles soluble antibody stimulation as revealed by BOOST phosphotyrosine proteomics | bioRxiv
Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity | The EMBO Journal
Pathogen manipulation of B cells: the best defence is a good offence | Nature Reviews Microbiology
The landscape of bispecific T cell engager in cancer treatment | Biomarker Research | Full Text
Adaptive immunity and SARS-CoV-2
